PMID: 8956332Nov 1, 1996Paper

Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo

Pharmaceutical Research
H L LuessenH E Junginger

Abstract

To evaluate the effect of the crosslinked poly(acrylate) carbomer 934P (C934P) and its freeze-dried neutralized sodium salt (FNaC934P) as well as chitosan hydrochloride on the intestinal absorption of the peptide drug buserelin. Buserelin was applied intraduodenally in control buffer, 0.5% (w/v) C934P, 0.5% (w/v) FNaC934P, 1.5% (w/v) chitosan hydrochloride or FNaC934P/chitosan hydrochloride (1:1 (v/v)) mixture in rats. All polymer preparation showed a statistically significant improvement of buserelin absorption compared to the control solution. The absolute bioavailabilities for the different polymer preparations were: control, 0.1%; 0.5% FNaC934P, 0.6%; 0.5% C934P, 2.0%; chitosan hydrochloride, 5.1% and FNaC934P/chitosan hydrochloride (1:1 (v/v)) mixture, 1.0%. The higher bioavailability with chitosan hydrochloride compared to C934P and FNaC934P indicates that for buserelin the intestinal transmucosal transport enhancing effect of the polymer plays a more dominant role than the protection against proteases such as alpha-chymotrypsin. The mucoadhesive polymers carbomer 934P and chitosan hydrochloride are able to enhance the intestinal absorption of buserelin in vivo in rats, and may therefore be promising excipients in peroral...Continue Reading

Citations

Apr 5, 2001·Clinical Pharmacokinetics·J Woodley
Jul 5, 2006·Chemical & Pharmaceutical Bulletin·Richer ChenKazumi Danjo
Oct 3, 2006·Drug Development and Industrial Pharmacy·Catarina M SilvaPhilippe Arnaud
Sep 22, 2007·The Journal of Pharmacy and Pharmacology·Alexander GreimelAndreas Bernkop-Schnürch
Mar 20, 2009·Pharmaceutical Research·Nelly FransénErik Björk
Nov 21, 2012·Expert Opinion on Drug Delivery·Hendrik J R Lemmer, Josias H Hamman
May 13, 2014·Expert Opinion on Drug Delivery·Alice L SmartAbdul W Basit
Jan 7, 1999·Drug Development and Industrial Pharmacy·C LiT P Johnston
Jul 29, 2000·Drug Development and Industrial Pharmacy·A K SinglaA Singh
Apr 2, 2005·Drug Delivery·M Prabaharan, J F Mano
Nov 22, 2005·Expert Opinion on Drug Delivery·Cecilia PregoMaria Jose Alonso
Mar 17, 2007·Journal of Drug Targeting·Florian FögerAndreas Bernkop-Schnürch
May 11, 2007·Expert Opinion on Drug Delivery·Masuo Kondoh, Kiyohito Yagi
May 1, 2008·Drug Delivery·I Tuncer DeğimFüsun Acartürk
Aug 8, 2008·Drug Development and Industrial Pharmacy·Gill M EnslinAwie F Kotze
Dec 30, 2008·Journal of Materials Science. Materials in Medicine·V K Mourya, Nazma N Inamdar
Nov 5, 2010·Chemical & Pharmaceutical Bulletin·Kalpana NagpalDina Nath Mishra
Sep 9, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hirofumi Takeuchi, Hikaru Sugihara
Jul 22, 2011·Drug Development and Industrial Pharmacy·Wei ChenXing Tang
Nov 19, 2015·Biomaterials Science·Juliana de Almeida Pachioni-VasconcelosCarlota de Oliveira Rangel-Yagui
Jun 29, 2018·Interventional Medicine & Applied Science·Vikash KumarAnjoo Kamboj
Nov 12, 2003·The Journal of Pharmacology and Experimental Therapeutics·Xueying YanQiang Zhang
Aug 29, 2007·International Journal of Nanomedicine·Katherine Bowman, Kam W Leong
Feb 21, 2008·The Journal of Pharmacy and Pharmacology·Martin Werle, Andreas Bernkop-Schnürch
May 1, 2010·Drug Delivery·Lissinda H du PlessisHans E Junginger
Jun 19, 2012·Expert Opinion on Drug Delivery·Sabine Hauptstein, Andreas Bernkop-Schnürch
May 29, 2012·Journal of Drug Targeting·Seung Woo ChungYoungro Byun
Jan 17, 2017·Drug Discoveries & Therapeutics·Akihiro MatsumotoMasahiro Murakami
Jan 31, 2018·The Journal of Pharmacy and Pharmacology·Swati Chaurasiya, Vijay Mishra
Dec 6, 2010·Materials·Roberto Ruiz-Caro, María D Veiga
Dec 1, 2015·Journal of Food and Drug Analysis·M Abd ElgadirMd Zaidul Islam Sarker
Sep 16, 2020·International Journal of Molecular Sciences·Angela FabianoYlenia Zambito
Jun 28, 2006·Journal of Microencapsulation·J VarshosazS Golafshan
Aug 2, 2006·Biological & Pharmaceutical Bulletin·Mojca Kerec KosAles Mrhar
Nov 3, 2010·Journal of Drug Targeting·Barbara C Baudner, Derek T O'Hagan
May 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rita P AquinoFrancesca Sansone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.